Robert Hershberg

Dr. Hershberg was the chief scientific officer and EVP and head of business development and global alliances at Celgene, joining the company in 2014. Previously, he co-founded VentiRx Pharmaceuticals Inc. in 2006, and was CEO from 2012 until the company’s acquisition by Celgene in 2017. He is currently a clinical faculty member at the University of Washington School of Medicine.

  • October 2020

Added to: Recursion Pharma - Salt Lake City, UT

Recursion is a digital biology company industrializing drug discovery. They do this by combining automation, artificial intelligence, and machine learning to discover novel medicines. The biological images generated in-house on the company's robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry and potential toxicity with the goal of decoding biology and new therapeutics.